Developing a New Class of Therapies Based on a Natural Cargo Carrier

Tony de Fougerolles, CEO of Evox Therapeutics, discusses exosomes, the company’s platform technology to load these natural transport vehicles with therapeutic cargo, and how it is using this approach to target a range of rare diseases.